Shaobo F. Wang

Shandong Key Laboratory Of Brain Health And Function Remodeling
Jinan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

IL-17D reprograms CD93+ antigen-presenting cells in the glioblastoma microenvironment.

IL-17D reprograms CD93+ antigen-presenting cells in the glioblastoma microenvironment.

Journal: Cellular & molecular immunology
Published: December 21, 2025

Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma.

Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma.

Journal: Cell death & disease
Published: June 21, 2025

O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner.

O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner.

Journal: Neuro-oncology
Published: December 13, 2024

HDAC7 drives glioblastoma to a mesenchymal-like state via LGALS3-mediated crosstalk between cancer cells and macrophages.

HDAC7 drives glioblastoma to a mesenchymal-like state via LGALS3-mediated crosstalk between cancer cells and macrophages.

Journal: Theranostics
Published: July 14, 2024

Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress.

Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress.

Journal: Neuro-oncology
Published: January 29, 2024

Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop.

Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop.

Journal: Journal of nanobiotechnology
Published: March 21, 2023

Neuronal Activity Promotes Glioma Progression by Inducing Proneural-to-Mesenchymal Transition in Glioma Stem Cells.

Neuronal Activity Promotes Glioma Progression by Inducing Proneural-to-Mesenchymal Transition in Glioma Stem Cells.

Journal: Cancer research
Published: February 23, 2023

Hypoxia-Induced Neuronal Activity in Glioma Patients Polarizes Microglia by Potentiating RNA m6A Demethylation.

Hypoxia-Induced Neuronal Activity in Glioma Patients Polarizes Microglia by Potentiating RNA m6A Demethylation.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 12, 2023

Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia.

Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia.

Journal: Cell death & disease
Published: August 16, 2022

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma.

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma.

Journal: Cancer cell international
Published: May 25, 2022

MicroRNA-588 regulates the invasive, migratory and vasculogenic mimicry-forming abilities of hypoxic glioma cells by targeting ROBO1.

MicroRNA-588 regulates the invasive, migratory and vasculogenic mimicry-forming abilities of hypoxic glioma cells by targeting ROBO1.

Journal: Molecular biology reports
Published: April 15, 2022

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.

Journal: Journal of experimental & clinical cancer research : CR
Published: April 08, 2022
Showing 1-12 of 38

Last Updated: 09/26/2026